000			01412cam a22003258i 4500
001			19420750
003			OSt
005			20250205154824.0
008			161223s2017 enk b 001 0 eng
010			_a 2016059298
020			_a9781119289746 (pbk.)
020			_z9781119289784 (epub)
035			_a(DNLM)101697888
040			_aDNLM/DLC _cDLC _erda
050	0	0	_aRM302.5 _b.W35 2017
100	1		_aWaller, Patrick, _d1957 January 30- _eauthor.
245	1	3	_aAn introduction to pharmacovigilance / _cPatrick Waller, Mira Harrison-Woolrych.
250			_a2nd edition.
263			_a1707
264		1	_aChichester, West Sussex, UK ; _aHoboken, NJ : _bJohn Wiley & Sons Inc., _c[2017]
300			_a170p. ; _ccm.
504			_aIncludes bibliographical references and index.
505	0		_aWhat is pharmacovigilance and how has it developed? -- Basic concepts -- Types and sources of data -- The process of pharmacovigilance -- Regulatory aspects of pharmacovigilance -- International collaboration -- Clinical aspects of adverse drug reactions -- Ethical and societal considerations -- Future directions -- Learning more about pharmacovigilance.
650	1	2	_aPharmacovigilance
650	2	2	_aDrug Monitoring _xmethods
650	2	2	_aDrug-Related Side Effects and Adverse Reactions
650	2	2	_aPharmaceutical Preparations _xstandards
700	1		_aHarrison-Woolrych, Mira, _eauthor.
942			_2lcc _cBK
999			_c20619 _d20618